CymaBay Therapeutics, Inc.

Legal & General Group Plc

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/29/2025

Shares

86,244

Value ($000)

2,037

Weight

0.0%

2019 Q4 - 2023 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/29/2025	2,037	0.0%	86,244	12/31/2023
2023 Q3	11/14/2023	1,240	0.0%	83,189	9/30/2023
2023 Q2	8/14/2023	843	0.0%	76,957	6/30/2023
2023 Q1	5/15/2023	319	0.0%	36,585	3/31/2023
2022 Q1	5/16/2022	23	0.0%	7,302	3/31/2022
2021 Q4	2/14/2022	19	0.0%	5,558	12/31/2021
2021 Q3	11/15/2021	20	0.0%	5,558	9/30/2021
2021 Q2	8/12/2021	24	0.0%	5,558	6/30/2021
2021 Q1	5/17/2021	43	0.0%	9,457	3/31/2021
2020 Q4	2/12/2021	54	0.0%	9,457	12/31/2020
2020 Q3	11/13/2020	44	0.0%	6,106	9/30/2020
2020 Q2	8/14/2020	30	0.0%	8,503	6/30/2020
2020 Q1	5/14/2020	20	0.0%	13,434	3/31/2020
2019 Q4	2/13/2020	32	0.0%	16,404	12/31/2019